Liver International · 2005 · 53 citations · 18 references
MedicineOncologyHepatologyMolecular VirologyVirologyCirrhosisHepatocellular CarcinomaInterferon-based TherapyLiver CancerLiver DiseaseViral HepatitisHepatitis B Surface Antigen ClearanceHepatitis B Virus GenotypeHepatitis C GenotypesHepatitis C Virus GenotypeHepatocellular Carcinoma PathogenesisSerum Alanine AminotransferaseViral Hepatitis-related CirrhosisViral Load Assessment
AIM/BACKGROUND: Hepatitis B virus (HBV) is an important factor in the development of hepatocellular carcinoma (HCC). We studied the influence of HBV viral load on HCC occurrence in HBV related liver cirrhosis (LC). PATIENTS AND METHODS: Ninety-one LC patients were followed up over a period of 7 years. Twenty three patients received Interferon (IFN) therapy. RESULTS: In 7 years, 23 patients developed HCC. Of them twenty-two (95.6%) were of genotype C. HBV DNA was found to be the only significant variable associated with HCC occurrence on both univariate (P = 0.029) and multivariate analysis (odds ratio 2.33; P < 0.033). The cumulative survival at 5 years was 83% and the annual rate of hepatitis B surface antigen clearance was 0.9 %. All of 17 HCC patients observed over a period of 5 years or more belonged to the continuously high HBV DNA group (annual average >3.7 log copies/ml) and all but one belonged to the continuously high alanine aminotransferase group (annual average >40 IU/l). CONCLUSION: Patients with genotype C and a continuously high HBV DNA for 5 years or more are at a high-risk group for HCC development. Maintaining continuously low HBV DNA for 3 years or more with anti-viral therapy, may be useful in preventing or delaying HCC occurrence.
18
HBx gene of hepatitis B virus induces liver cancer in transgenic mice
Chang‐Min Kim, K. Koike, Izumu Saito et al. · Nature · 1991 · 1.2K citations
Abrogation of p53-Induced Apoptosis by the Hepatitis B Virus X Gene
Xin Wei Wang · Humana Press eBooks · 2003 · 321 citations · Full text